Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2

Lupus nephritis (LN) is the most frequent phenotype in patients with systemic lupus erythematosus (SLE) and has a high rate of progression to end-stage renal disease, in spite of intensive treatment and maintenance therapies. Recent evidence suggests that protease-activated receptor-2 (PAR2) is a th...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Yohan, Mun, Chin Hee, Park, So-Hyeon, Jeon, Dongkyu, Kim, Su Jeong, Yoon, Taejun, Ko, Eunhee, Jo, Sungwoo, Park, Yong-Beom, Namkung, Wan, Lee, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404282/
https://www.ncbi.nlm.nih.gov/pubmed/32674502
http://dx.doi.org/10.3390/ijms21144975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404282/
https://www.ncbi.nlm.nih.gov/pubmed/32674502
http://dx.doi.org/10.3390/ijms21144975

Ejemplares similares